Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in burkitt's lymphoma cell lines

Cytokine

Volumn 7, Issue 1, 1995, Pages 1-7

  Kube, D ^a   Platzer, C ^b   Von Knethen, A ^a   Straub, H ^a   Bohlen, H ^a   Hafner, M ^a   Tesch, H ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Burkitt's lymphoma; Human IL 10 promoter

Indexed keywords

EID: 0028945987     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1995.1001     Document Type: Article

References (24)

1. Moore KW, O’Garra A, de Waal Malefyt R, Vieria P, Mosmann RT (1993) IL-10. Ann Rev Immunol 11: 165-190.
2. Vieria P, de Waal Malefyt R, Dang MN, Johnson KE, Kastlein R, Fiorentino DF, de Vries JE, Roncarollo MG, Mosmann TR. Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clone: homology to Epstein-Barr virus open reading frame BCRFL. Proc Nat Acad Science 88: 1172-1176.
3. Fiorentino DF, Zlotnik A. Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
4. Ding L, Shevach EM (1992) IL-10 inhibits milogen-induced T-cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148: 3133-3139.
5. Bogdan C. Paik J, Vodovotz Y, Nathan C (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-b and interlcukin-10. J Biol Chem 267: 23301-23308.
6. Bcjaro MT, de Waal Maiefyt R, Abrams JS, Bigler M, Bacchetta R. de Vries J, Roncarolo MG (1992) Interleukin inhibits allogenic proliferative and cytotoxic T-cell response generated in primary mixed lymphocyte cultures. Int Immun 4: 1389-1397.
7. de Waal Malefyt R, Haancn J, Spits H, Roncarolo MG, te Velde A. Figdor C, Johnson K, Kastelein R. Yssel H, de Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915-924.
8. O’Garra A, Chang R, Go N, Hastings R, Haughton G. Howard M (1992) Ly-1 B (B-l) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22: 711-717.
9. Rousset F, Garcia E, Dcfrance T, Pcronne C, Vezzio N, Hsu DH, Kastclcin R, Moore KW, Banchereau J (1992) Interleukin is a potent growth and differentiation factor for activated human B lymphocytes. Proc Nat Acad Sc 89: 1890-1893.
10. Burdin N, Péronnc C. Banchereau J, Rousset F (1993) Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 177: 295-304.
11. Benjamin D, Knobloch TJ, Dayton MA (1992) Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt’s lymphoma constitutively secrete large quantities of interleukin-10. Blood 80: 1289-1298.
12. Kube D. Platzer C. von Knethen A, Fanai S, Bohlen H. Tesch T, Diehl V (1994) The influence of EBV on the regulation of the IL-10 promoter in Burkitt lymphomas. J Cell Biochem, Suppl 18c: 232.
13. Sjöberg, Nakagami H, Dolcetti R, Bejaro MT, Pisa P, Kiessling R, Masucci MG (1994) The Epstein-Barr virus encoded membrane protein LMP1 induces interleukin 10 production in Burkitt’s lymphoma lines. J Cell Biochem, Suppl 18c: 233.
14. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC (1993) Serum IL-10 in non-Hodgkin-lymphoma: a prognostic factor. Blood 7: 2169-2174.
15. Richter G. Krüger-Krasagakes S, Hein G, Hüls C. Schmitt E, Diamantstein T. Blankenstein T (1993) IL-10 transfected into Chinese hamster ovary cells prevents tumour growth and macrophage infiltration. Canccr Res 53: 4134-4137.
16. Holland G, Zlotnik A (1993) Interleukin 10 and cancer. Cancer Invest 11: 751-758.
17. Kim JM, Brannan Cl, Copeland NG, Jenkins NA, Khan TA, Moore KW (1992) Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148: 3618-3623.
18. Moore KW, Vieria P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 1230-1233.
19. Locker J, Buzard G (1990) A dictionary of transcription control sequences. DNA Seq J DNA Scq Map 1: 3.
20. Abe E, de Waal Malefyt R, Matsuda I, Arai N (1992) An 11-base pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc Nat Acad Science 89: 2864-2868.
21. Zimber-Strobel U, Kremme E, Grässer F, Marschall G, Laux G, Bornkamm GW (1993) The Epstein-Barr virus antigen 2 interacts with an EBNA2 responsive cis element of the terminal protein 1 gene promoter. EMBO J 12: 167-175.
22. Jones NC, Rigby PWJ, Ziff EB (1988) Trans-acting protein factors and the regulation of cukaryotic transcription: the lessons from DNA tumor viruses. Genes Devel 2: 267.
23. Wang F, Tsang SF, Kurilla M. Cohen JI, Kicff E (1990) Epstein-Barr virus nuclear antigen 2 transactivatcs latent membrane protein LMP1. J Virol 64: 3407-3413.
24. Murray RJ, Young LS, Calendar A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB (1988) Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-ceil lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains. J Virol 1988: 894-901.